Insulinoma surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 9: | Line 9: | ||
===Benign Tumors=== | ===Benign Tumors=== | ||
*90% | |||
*Small well-encapsulated, solitary tumors: | |||
:*Surgical resection is treatment of choice (minimal invasive surgery) | |||
::*Enucleation | |||
::*Partial pancreatectomy | |||
::*Middle pancreatectomy | |||
* | *Multiple, unencapsulated, >4 cm in diameter, and involves or is near the main pancreatic duct: | ||
:*Radical resection | |||
* | |||
===Malignant Tumors=== | ===Malignant Tumors=== |
Revision as of 15:08, 7 October 2015
Insulinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Insulinoma surgery On the Web |
American Roentgen Ray Society Images of Insulinoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Surgery
The definitive management is surgical removal of the insulinoma. This may involve removing part of the pancreas as well (Whipple procedure and distal pancreatectomy).
Benign Tumors
- 90%
- Small well-encapsulated, solitary tumors:
- Surgical resection is treatment of choice (minimal invasive surgery)
- Enucleation
- Partial pancreatectomy
- Middle pancreatectomy
- Multiple, unencapsulated, >4 cm in diameter, and involves or is near the main pancreatic duct:
- Radical resection
Malignant Tumors
- 10%
- Aggressive surgical resection, including extended pancreatic resection, liver resection, and/or liver transplantation
- Post-surgical chemoembolization or radiofrequency ablation of tumors to control hypoglycemia
Unresectable Tumors
- Octreotide administration
- Continous glucose monitoring